• Profile
Close

Hypermethylation of DcR1, DcR2, DR4, DR5 gene promoters and clinical significance in tongue carcinoma

American Journal of Otolaryngology - Head and Neck Medicine and Surgery Nov 21, 2019

Zhou Y, et al. - Researchers conducted this investigation to explore the correlation of methylation of DcR1, DcR2, DR4 and DR5 gene promoters and clinical significance in the tongue squamous cell carcinoma (TSCC), one of the most common malignancies in the oral cavity, to assess the link between methylation of DcR1, DcR2, DR4 and DR5 gene and Clinical Significance in TSCC. They used methylation-specific PCR(MSP) to investigate the methylation of the promoters of TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) receptors in 45 TSCC cases. To detect the expression of the DcR1, DcR2, DR4 and DR5 gene, Real-Time PCR was utilized. According to results, TSCC finds methylation of promoters DcR1, DcR2, DR4 and DR5 and may be correlated with its occurrence and development. Considering methylation reversibility, methylation is a potential targeted TSCC therapy.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay